The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Prodigiosin results in decreased expression of BIRC5 mRNA; Prodigiosin results in decreased expression of BIRC5 protein Prodigiosin inhibits the reaction [Paclitaxel results in increased expression of BIRC5 protein] BIRC5 results in decreased susceptibility to Prodigiosin
Prodigiosin results in increased cleavage of CASP3 protein Prodigiosin results in increased activity of CASP3 protein Acetylcysteine inhibits the reaction [Prodigiosin results in increased activity of CASP3 protein] Prodigiosin inhibits the reaction [Aluminum Chloride results in increased activity of CASP3 protein]
2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide inhibits the reaction [Prodigiosin results in increased expression of and results in increased phosphorylation of JUN protein]; Prodigiosin results in increased expression of and results in increased phosphorylation of JUN protein
2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide inhibits the reaction [Prodigiosin results in increased expression of and results in increased phosphorylation of MAPK1 protein]; Prodigiosin results in increased expression of and results in increased phosphorylation of MAPK1 protein
2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide inhibits the reaction [Prodigiosin results in increased expression of and results in increased phosphorylation of MAPK3 protein]; Prodigiosin results in increased expression of and results in increased phosphorylation of MAPK3 protein
Prodigiosin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of NOS2 protein] Prodigiosin inhibits the reaction [Aluminum Chloride results in increased expression of NOS2 mRNA]
pyrazolanthrone inhibits the reaction [Prodigiosin results in decreased expression of RAD51 mRNA]; SB 203580 inhibits the reaction [Prodigiosin results in decreased expression of RAD51 mRNA] Prodigiosin results in decreased expression of RAD51 mRNA; Prodigiosin results in decreased expression of RAD51 protein RAD51 protein results in decreased susceptibility to Prodigiosin
Prodigiosin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] affects the localization of RELA protein] Prodigiosin inhibits the reaction [Aluminum Chloride results in increased expression of RELA protein]
Prodigiosin results in increased expression of SQSTM1 protein 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide inhibits the reaction [Prodigiosin results in increased expression of SQSTM1 protein]